CARY, N.C.--(BUSINESS WIRE)--Focal Medical, Inc., a privately held, biopharmaceutical company developing novel precision therapeutic products today announced successful completion of the nonclinical ...
ACT-IOP-003 is an implantable iontophoretic product designed to safely achieve high concentration of gemcitabine in the pancreas, via non-circulatory pathways and with little to no systemic drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback